Cell Surface Marker Detection Global Market Report 2024

The global cell surface marker detection market has grown strongly in recent years. It will grow from $5.52 billion in 2023 to $6.06 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth observed in the historical period can be attributed to several factors, including the expansion of biomedical research, the evolution of high-content screening methodologies, and an increase in the prevalence of chronic diseases, and a notable shift towards immunotherapy. These factors collectively contributed to the growth witnessed during that timeframe.

The global cell surface marker detection market is expected to see rapid growth in the next few years. It will grow to $8.95 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be attributed to several factors, including market expansion in emerging economies, the continuous growth of the biopharmaceutical sector, increased adoption of single-cell analysis, a rise in both chronic and infectious diseases, and the escalating funding for life sciences research. Key trends expected in the forecast period encompass advancements in biotechnology, ongoing product innovations, technological enhancements in flow cytometry, and a growing prevalence of chronic diseases. These trends collectively contribute to the projected growth in the upcoming period.

The increasing prevalence of oncology diseases is set to drive the growth of the cell surface marker detection market. Oncology, characterized by uncontrolled cell growth and spread, has seen a rise attributed to factors like Western lifestyles, poor dietary habits, pollution, and a lack of exercise. Cell surface marker detection plays a crucial role in predicting patient responses to cancer drugs, aiding in point-of-care decisions. Macmillan Cancer Support's October 2022 estimate indicated 3 million people with cancer in 2020, projected to increase to 5.3 million by 2040. This surge in oncology diseases underlines the demand for cell surface marker detection in the market.

The growth of chronic diseases is anticipated to further propel the cell surface marker detection market. Chronic diseases, persistent medical conditions progressing slowly over time, are on the rise globally. Cell surface marker detection contributes to the diagnosis, monitoring, and treatment of chronic diseases, enabling targeted and personalized care. The World Health Organization's September 2022 data highlighted 41 million deaths annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases. The prevalence of chronic diseases, including cardiovascular diseases, cancer, respiratory diseases, and diabetes, is a significant driver for the cell surface marker detection market.

Product innovation emerges as a key trend in the cell surface marker detection market, with major companies focusing on developing new products to meet customer demands. Bio-Rad Laboratories Inc.'s June 2021 announcement of three StarBright Dyes designed for flow cytometry exemplifies this trend. These dyes, brighter than existing fluorescent options, offer researchers improved resolution for rare populations and low-density antigens. This emphasis on product innovation enhances the capabilities of cell surface marker detection, meeting evolving research needs and market demands.

Innovations in analysis systems, such as imaging analysis systems, provide a competitive edge in the cell surface marker detection market. CytoSMART Technologies BV's launch of CytoSMART Omni FL in April 2022 is an example of this trend. This fluorescence live-cell imaging analysis system, featuring a high-resolution CMOS camera, enables the observation of dynamic cellular processes. Used in various fields, including stem cell biology and immuno-oncology, such technologies contribute to advancing research capabilities and strengthening market competitiveness.

In July 2021, DiaSorin S.p.A's acquisition of Luminex Corporation for USD 1.8 billion exemplifies strategic moves within the cell surface marker detection market. DiaSorin gains access to Luminex's multiplexing technology, enhancing its existing offerings and expanding its position, particularly in the United States. Luminex Corporation's technologies in biological testing align with DiaSorin's objectives, showcasing the significance of strategic acquisitions in shaping the competitive landscape of the cell surface marker detection market.

Major companies operating in the cell surface marker detection market report are Thermo Fisher Scientific Inc., Beckman Coulter Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Sartorius, Becton Dickinson and Company, BD Biosciences, Grifols SA, Applied Microarrays Inc., R&D Systems, Agilent Inc., Sigma-Aldrich, Qiagen NV, Sysmex Corporation, Nihon Kohden Corporation, Abnova Corporation, Diasorin SpA, Janssen Diagnostics, Biorad Laboratories, Abcam PLC, GenScript Biotech, BioLegend, Cell Signaling Technology Inc., Merck KGaA, Bio-Techne Corporation, Affymetrix, Danaher Corporation, Zymo Research Corporation, and Miltenyi Biotec

North America was the largest region in the cell surface marker detection market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell surface marker detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products associated with cell surface marker detection include flow cytometry, hematology analyzers, and various reagents and kits. Flow cytometry is a laboratory test that analyzes the properties of cells or particles suspended in fluid. During the procedure, a sample is injected into a flow cytometer machine, and a computer can rapidly evaluate and process a large number of cells. Flow cytometry is commonly used to assess bone marrow, peripheral blood, and other bodily fluids, playing a crucial role in disease diagnosis, diseases identification, drug discovery research, and cytological academic research. These products are utilized by a range of entities, including pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, academic and research institutes, among others. They contribute significantly to advancements in medical research, diagnostics, and drug development.

This report provides cell surface marker detection market statistics, including cell surface marker detection industry global market size, regional shares, competitors with a cell surface marker detection market share, detailed cell surface marker detection market segments, market trends and opportunities, and any further data you may need to thrive in the cell surface marker detection industry. This cell surface marker detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell surface marker detection market consists of revenues earned by entities by providing cell surface marker detection services such as cell analysis, fluorescence-activated cell sorting (FACS) analysis, immunohistochemistry, blood test, Tbnk test. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell surface marker detection market also includes sales of kits, dyes, analyzers equipment which are used in providing cell surface marker detection services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.